April 20, 2021 Solutions Exist To Regenerative Medicine's Most Pressing Manufacturing Challenges
Yatindra Tirunagari, head of production DSP at Rentschler ATMP Ltd., joined industry experts in an interview with the ‘in vivo’ magazine and shared solutions to key manufacturing challenges, such as lowering cost of goods and centralized manufacturing, in the cell and gene therapy sector. While elaborating on the many advantages of partnering with an experienced CDMO, Tirunagari said, “Working with a CDMO can offer a competitive edge to small and mid-sized companies, for example those that have a limited pipeline catering to rare and ultra-rare diseases. Capacity constraints can be resolved through innovative manufacturing set-up and operations.”
Please follow this link to read the entire article here.
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication